Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video]Spotlight on Pharma Deals
CNBC
Monday, August 30, 2010 - 6:16pm
tags:
M&A, Genzyme, Sanofi, GSK, Pfizer
The Quote Of The Week: J&J CEO Should Resign
Pharmalot
Monday, August 30, 2010 - 12:27pm
tags:
William Weldon, JNJ, Pharma CEOs
Top 10 Women in Biotech
Fierce Biotech
Monday, August 30, 2010 - 12:24pm
tags:
women, biotech
Pfizer settles Prempro case, avoiding retrial
Fierce Pharma
Monday, August 30, 2010 - 12:23pm
tags:
Pfizer, HRT, Wyeth, settlements, Prempro
BioMarin's Pompe disease drug gets orphan status
Yahoo/AP
Monday, August 30, 2010 - 12:22pm
tags:
Biomarin, Pompe disease, orphan drugs
Genzyme: Whitworth, Icahn Could Push Sanofi to $80
Barron's
Monday, August 30, 2010 - 12:20pm
tags:
Genzyme, Icahn, M&A, Sanofi
Eisai's Anti-Clotting Drug May Cut Heart Risks Without Increased Bleeding
Bloomberg
Monday, August 30, 2010 - 11:21am
tags:
Eisai, anti-clotting
Sanofi's Experimental Oral Multiple Sclerosis Treatment Reduces Relapses
Bloomberg
Monday, August 30, 2010 - 11:18am
tags:
Sanofi, MS, teriflunomide, Merck KGaA, multiple sclerosis, Novartis
Inspire-Allergan Amend Deal Terms
Yahoo/Zacks.com
Monday, August 30, 2010 - 11:16am
tags:
M&A, Allergan, Inspire
Forest-Gedeon Richter drug misses overall goal
Marketwatch
Monday, August 30, 2010 - 11:15am
tags:
biopolar depression, cariprazine, Geodon Richter, Forest Labs
InVivo's Deals of the Week
InVivo
Monday, August 30, 2010 - 11:08am
tags:
M&A, Roche, Bioimagene, Aileron, Cypress Bioscience, Alexza, Marina, 3SBio, Isotechnika
Sanofi-Aventis CEO vows discipline in Genzyme bid
Marketwatch
Monday, August 30, 2010 - 11:04am
tags:
Sanofi, Pharma CEOs, M&A, Genzyme, Chris Viehbacher
Vivus' Qnexa Panel Bodes Well for Arena's Obesity Drug
Seeking Alpha
Monday, August 30, 2010 - 10:44am
tags:
Qnexa, Vivus, advisory panels, Arena Pharmaceuticals, obesity
Is Roche Planning ‘Massive’ Job Cuts?
Pharmalot
Monday, August 30, 2010 - 10:40am
tags:
Roche, layoffs
Pfizer, Bayer, Boehringer Bid to Replace Warfarin in Stroke-Drug Market
Bloomberg
Monday, August 30, 2010 - 10:39am
tags:
Pfizer, Bayer, Boehringer Ingelheim, Warfarin, Pradaxa, blood thinners
AstraZeneca says blood thinner met key study goals
Yahoo/AP
Monday, August 30, 2010 - 10:32am
tags:
blood thinners, AstraZeneca, FDA, Ticagrelor, Sanofi, Plavix, Bristol-Myers Squibb
J&J Plagued by Product Recalls
Yahoo/Zacks.com
Monday, August 30, 2010 - 10:05am
tags:
recalls, JNJ, DePuy
Genzyme Rejects Sanofi's $18.5B Offer
TheStreet.com
Monday, August 30, 2010 - 10:04am
tags:
Genzyme, Sanofi, M&A
Sanofi Goes Public With Genzyme Offer for First Time .
WSJ
Sunday, August 29, 2010 - 1:10pm
tags:
Sanofi, Genzyme, M&A
Big Pharma: Why In-Licensing Is Not the Cure
SeekingAlpha
Sunday, August 29, 2010 - 1:07pm
tags:
Big Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.